• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服睾酮:重新评估

Oral testosterone, a reappraisal.

作者信息

Daggett P R, Wheeler M J, Nabarro J D

出版信息

Horm Res. 1978;9(3):121-9. doi: 10.1159/000178904.

DOI:10.1159/000178904
PMID:640576
Abstract

A microparticulate form of free testosterone was given orally to 6 hypogonadal men. Plasma levels were followed after a 200-mg dose, and a double-peak effect was observed. This suggests that particles of different sizes were absorbed at different rates. The clinical and biochemical effects were observed over a 2-month period, on a dose of 200 mg twice daily, taken in place of the usual androgen replacement. The results indicate that absorption is not sufficiently reliable for routine use. The large doses required to achieve therapeutic levels, make oral administration of free testosterone impractical.

摘要

将游离睾酮的微粒形式口服给予6名性腺功能减退男性。给予200毫克剂量后监测血浆水平,观察到双峰效应。这表明不同大小的颗粒以不同速率被吸收。在2个月期间观察临床和生化效应,剂量为每日两次200毫克,取代通常的雄激素替代治疗。结果表明,吸收不够可靠,无法常规使用。达到治疗水平所需的大剂量使得游离睾酮口服给药不切实际。

相似文献

1
Oral testosterone, a reappraisal.口服睾酮:重新评估
Horm Res. 1978;9(3):121-9. doi: 10.1159/000178904.
2
Treatment of primary hypogonadism in men by the transdermal administration of testosterone.通过经皮给予睾酮治疗男性原发性性腺功能减退。
J Clin Endocrinol Metab. 1989 Feb;68(2):369-73. doi: 10.1210/jcem-68-2-369.
3
Treatment of hypogonadal adolescent boys with long acting subcutaneous testosterone pellets.用长效皮下注射睾酮丸治疗性腺功能减退的青春期男孩。
Arch Dis Child. 1997 Jun;76(6):495-9. doi: 10.1136/adc.76.6.495.
4
Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men.睾酮替代疗法对老年性腺功能减退男性动脉僵硬度的影响。
Eur J Endocrinol. 2009 May;160(5):839-46. doi: 10.1530/EJE-09-0052. Epub 2009 Jan 27.
5
Androgen therapy in hypogonadotrophic hypogonadism: time course of erotosexual functions.低促性腺激素性性腺功能减退症中的雄激素治疗:性兴奋功能的时间进程。
Arch Androl. 1988;20(2):163-9. doi: 10.3109/01485018808987069.
6
Lowering prolactin level in a hyperprolactinemic man: responses of luteinizing hormone, follicle-stimulating hormone, and testosterone.降低高催乳素血症男性的催乳素水平:促黄体生成素、促卵泡生成素和睾酮的反应。
Arch Intern Med. 1982 Jan;142(1):146-8.
7
Pulsatile gonadotropin-releasing hormone in gonadotropin deficient and normal men: suppression of follicle-stimulating hormone responses by testosterone.促性腺激素缺乏和正常男性体内的脉冲式促性腺激素释放激素:睾酮对促卵泡激素反应的抑制作用
J Clin Endocrinol Metab. 1981 Jul;53(1):184-91. doi: 10.1210/jcem-53-1-184.
8
Normal adults and subjects with hypogonadotropic hypogonadism respond differently to D-Ser(TBU)6-LH-RH-EA10.正常成年人和促性腺激素缺乏性性腺功能减退患者对D-Ser(TBU)6-LH-RH-EA10的反应不同。
J Clin Endocrinol Metab. 1979 Jan;48(1):167-70. doi: 10.1210/jcem-48-1-167.
9
Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost.枸橼酸氯米酚和睾酮凝胶替代疗法治疗男性性腺功能减退症:疗效和治疗费用。
J Sex Med. 2010 Jan;7(1 Pt 1):269-76. doi: 10.1111/j.1743-6109.2009.01454.x. Epub 2009 Aug 17.
10
Treatment of male hypogonadism with testosterone enanthate.庚酸睾酮治疗男性性腺功能减退
J Clin Endocrinol Metab. 1980 Dec;51(6):1335-9. doi: 10.1210/jcem-51-6-1335.

引用本文的文献

1
A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism.一种新的口服睾酮(TLANDO)治疗方案,无需剂量滴定,适用于男性性腺功能减退症。
Andrology. 2022 May;10(4):669-676. doi: 10.1111/andr.13153. Epub 2022 Jan 18.
2
Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age.随着男性年龄的增长,睾丸激素疗法的药代动力学与血清睾丸激素水平的昼夜变化的关系。
Andrology. 2022 Feb;10(2):209-222. doi: 10.1111/andr.13108. Epub 2021 Oct 8.
3
An oral lipidic native testosterone formulation that is absorbed independent of food.
一种口服脂溶性天然睾酮制剂,不受食物影响而被吸收。
Eur J Endocrinol. 2021 Oct 5;185(5):607-615. doi: 10.1530/EJE-21-0606.
4
Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism.定量描述人肝和肠中的 UDP-葡糖醛酸基转移酶 2B17 及其在睾酮首过代谢中的作用。
Biochem Pharmacol. 2018 Oct;156:32-42. doi: 10.1016/j.bcp.2018.08.003. Epub 2018 Aug 4.
5
Intestinal lymphatic vasculature: structure, mechanisms and functions.肠道淋巴管系统:结构、机制与功能。
Nat Rev Gastroenterol Hepatol. 2017 Sep;14(9):510-526. doi: 10.1038/nrgastro.2017.79. Epub 2017 Jun 28.
6
Pharmacology of testosterone replacement therapy preparations.睾酮替代疗法制剂的药理学
Transl Androl Urol. 2016 Dec;5(6):834-843. doi: 10.21037/tau.2016.07.10.
7
Pharmacokinetics of modified slow-release oral testosterone over 9 days in normal men with experimental hypogonadism.实验性性腺功能减退的正常男性中改良缓释口服睾酮9天的药代动力学
J Androl. 2012 May-Jun;33(3):420-6. doi: 10.2164/jandrol.111.014514. Epub 2011 Aug 25.
8
Intestinal lymphatic transport for drug delivery.肠道淋巴转运用于药物递送。
Adv Drug Deliv Rev. 2011 Sep 10;63(10-11):923-42. doi: 10.1016/j.addr.2011.05.019. Epub 2011 Jun 13.
9
Oral testosterone with and without concomitant inhibition of 5α-reductase by dutasteride in hypogonadal men for 28 days.口服睾酮并同时合用非那雄胺抑制 5α-还原酶治疗 28 天的低雄激素血症男性。
J Urol. 2011 Feb;185(2):626-32. doi: 10.1016/j.juro.2010.09.089. Epub 2010 Dec 18.
10
Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasteride.口服十一酸睾酮与非那雄胺同时抑制5α-还原酶的稳态药代动力学。
Int J Androl. 2011 Dec;34(6 Pt 1):541-7. doi: 10.1111/j.1365-2605.2010.01120.x. Epub 2010 Oct 24.